Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06933199

Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis

Led by University Hospital Ostrava · Updated on 2025-05-04

260

Participants Needed

4

Research Sites

191 weeks

Total Duration

On this page

Sponsors

U

University Hospital Ostrava

Lead Sponsor

U

University Hospital Olomouc

Collaborating Sponsor

AI-Summary

What this Trial Is About

This multicentre proof-of-concept study, involving 4 centers, aims to establish the value of fractionated neoadjuvant stereotactic radiotherapy (NaSRT) as a new treatment paradigm for brain metastases (BM) in the frame of the Czech neurooncology network. Most relevant studies published to date used single-fraction radiotherapy and dealt with the inherent bias related to their retrospective nature. The researchers aim to increase the level of evidence for this treatment paradigm together with other similar ongoing studies.

CONDITIONS

Official Title

Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Karnofsky Performance Status of 60 or higher
  • Histologically confirmed primary cancer
  • MRI showing brain metastases
  • Brain metastases planned for surgical removal and other metastases suitable for radical stereotactic radiotherapy
  • Brain metastases measuring between 1 cm and 7 cm on MRI with contrast
Not Eligible

You will not qualify if you...

  • Confirmed blood-related cancers
  • Small-cell lung carcinoma
  • Emergency condition requiring immediate brain surgery
  • Previous whole-brain radiotherapy
  • Previous stereotactic radiotherapy to target brain metastases
  • Pregnancy
  • Inability to have brain metastasis surgery within 7 days after neoadjuvant stereotactic radiotherapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia, 70852

Actively Recruiting

2

Masaryk Memorial Cancer Institute

Brno, Czechia, 65653

Actively Recruiting

3

University Hospital Hradec Králové

Hradec Králové, Czechia, 50005

Actively Recruiting

4

University Hospital Olomouc

Olomouc, Czechia, 77900

Actively Recruiting

Loading map...

Research Team

J

Jiří Hynčica

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here